NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference
06 sept. 2023 16h00 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Sept. 06, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
14 août 2023 16h00 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Aug. 14, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14
08 août 2023 16h00 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common Stock
25 juil. 2023 08h00 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., July 25, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care...
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
24 juil. 2023 16h03 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., July 24, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care...
NeuroOne® Submits 510(k) Application to FDA for OneRF™ Ablation System
12 juin 2023 08h35 HE
|
NeuroOne Medical Technologies Corp
Potential for transformative improvement in neurosurgery as first known sEEG-guided RF system that records and ablates nervous tissue with the added benefit of temperature control EDEN PRAIRIE,...
NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode in Robotic Neurosurgery
17 mai 2023 09h00 HE
|
NeuroOne Medical Technologies Corp
Evo sEEG electrode used with Zimmer Biomet’s ROSA One® Brain during procedure at Cleveland Clinic EDEN PRAIRIE, Minn., May 17, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation...
NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
11 mai 2023 16h00 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® to Report Second Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on May 11
11 mai 2023 12h17 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode Performed at Mayo Clinic
10 mai 2023 09h00 HE
|
NeuroOne Medical Technologies Corp
Evo sEEG electrodes used for brain mapping in epilepsy surgery EDEN PRAIRIE, Minn., May 10, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the...